Novoprotein Scientific

Novoprotein Scientific EBIT Margin

The EBIT Margin (Operating Margin) of Novoprotein Scientific (688137.SS) as of Oct 19, 2026 is -45.54 %. In the previous year, EBIT Margin (Operating Margin) was -43.43 % — a change of 4.85% (lower).

EBIT Margin

-45.54 %

YoY

4.85%

Last updated:

EBIT Margin (Operating Margin) of Novoprotein Scientific is 2025 -45.54 % . EBIT Margin (Operating Margin) of Novoprotein Scientific was 2024 -43.43 % . It decreases by 4.85% lower compared to the previous year.

Novoprotein Scientific's operating (EBIT) margin stands at -45.5%, down from 56.7% several years earlier.

The Novoprotein Scientific EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
-24.44 CNY
Jan 1, 2020
52.90 CNY
Jan 1, 2021
56.70 CNY
Jan 1, 2022
42.68 CNY
Jan 1, 2023
-3.85 CNY
Jan 1, 2024
-43.43 CNY
Jan 1, 2025
-45.54 CNY
The Novoprotein Scientific EBIT Margin history
YEAREBIT MarginYoY
-45.54 %+4.85%
-43.43 %+1,029.28%
-3.85 %-109.01%
42.68 %-24.72%
56.70 %+7.19%
52.90 %-316.40%
-24.44 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Novoprotein Scientific Stock analysis

What does Novoprotein Scientific do? Novoprotein Scientific Inc, based in Suzhou, China, operates in the Health Care sector within Biotechnology. The company develops and sells recombinant protein solutions, including target and factor proteins, recombinant antibodies, enzymes, and reagents. Its products, such as novel coronavirus diagnostic antibodies and mRNA vaccine-related materials, serve biological medicine, life science research, in vitro diagnostics, and vaccine development. Employing 665 staff, Novoprotein serves domestic and international markets from its Suzhou headquarters. Novoprotein Scientific is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Novoprotein Scientific stock

EBIT Margin (Operating Margin) of Novoprotein Scientific is -45.54 % in 2025.

EBIT Margin (Operating Margin) of Novoprotein Scientific changed from -43.43 % to -45.54 %, representing a 4.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Novoprotein Scientific since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Novoprotein Scientific with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Novoprotein Scientific

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Novoprotein Scientific